# FDA Inspection 1107596 - Robin Kroll, M.D. - September 30, 2019

Source: https://www.keypedia.com/records/fda_inspections/robin-kroll-md/93956ef2-b92f-45a8-88af-6a81f74efbe9
Source feed: FDA_Inspections

> FDA Inspection 1107596 for Robin Kroll, M.D. on September 30, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1107596
- Company Name: Robin Kroll, M.D.
- Inspection Date: 2019-09-30
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1140724 - 2021-04-23](https://www.keypedia.com/records/fda_inspections/robin-kroll-md/ece6e57f-8242-4efd-8e9b-16cb381cfd10)
- [FDA Inspection 995557 - 2016-12-06](https://www.keypedia.com/records/fda_inspections/robin-kroll-md/26dd1fb3-e9b3-4be9-9ae6-26a0d151a629)
- [FDA Inspection 813700 - 2012-12-20](https://www.keypedia.com/records/fda_inspections/robin-kroll-md/a9d9057a-9f83-4159-9f88-11b27e5894be)

Company: https://www.keypedia.com/companies/robin-kroll-md/22099a0b-4f3b-4078-a5a6-684ae0867507

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c